Supplement Industry Offers Cautionary Tale For Mandatory Cosmetic GMPs
This article was originally published in The Rose Sheet
Roughly six years after publication of FDA’s final rule establishing mandatory Good Manufacturing Practices in the dietary supplement sector, the industry’s noncompliance rate was still at nearly 70% in fiscal 2013, according to FDA data. How GMP requirements are laid out in forthcoming federal legislation to update FDA’s cosmetics oversight program could dictate the potential challenge before industry.
You may also be interested in...
Getting A Jump On MoCRA Compliance; Due Diligence Now Will Lighten Load, Risks Later
Cosmetics companies should not sit idly waiting for FDA to clarify new requirements under the Modernization of Cosmetic Regulations Act, speakers agreed at the Independent Beauty Association’s 2023 Technical/Regulatory Forum. Companies should be reviewing products, people and processes, including those of contract manufacturers, to get ahead of the curve.
US Cosmetics Companies Doing Gap Analysis, Awaiting FDA Instruction In MoCRA’s First Year
Amin Talati Wasserman attorney Angela Diesch discusses the priorities, questions and concerns among companies facing end-of-year deadlines under the Modernization of Cosmetic Regulations Act enacted in the final days of 2022.
Attorneys On Modernized Cosmetic Regulations And New Litigation Risks
Greenberg Traurig and Hogan Lovells attorneys provide first breakdowns of the game-changing Modernization of Cosmetic Regulations Act, including the potential for new lawsuits and plaintiff tactics.